Integrated Wealth Concepts LLC Day One Biopharmaceuticals, Inc. Transaction History
Integrated Wealth Concepts LLC
- $9.24 Billion
- Q2 2025
A detailed history of Integrated Wealth Concepts LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Integrated Wealth Concepts LLC holds 20,170 shares of DAWN stock, worth $208,961. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,170
Previous 17,138
17.69%
Holding current value
$208,961
Previous $135,000
2.96%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DAWN
# of Institutions
178Shares Held
70.4MCall Options Held
59.6KPut Options Held
23.5K-
Atlas Venture Life Science Advisors, LLC6.43MShares$66.6 Million9.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$64 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$47 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.1MShares$42.5 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.72MShares$38.6 Million0.56% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $761M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...